NeuroPace, Inc. Announces Results of 7 Years of Clinical Trial Follow-up Demonstrating 72 Percent Seizure Reduction with the RNS® System - December 4, 2016

Is your patient 18 years of age or older?
- Yes
- No
The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.

Has your patient been diagnosed with epilepsy and tried at least 2 anti-seizure medications but still have seizures?
- Yes
- No

Does your patient average at least three seizures per month?
- Yes
- No
- I don't know

Have your patient's seizures been localized to one or two seizure foci?
- Yes
- No
- I don't know

What other procedures has your patient already tried? (Choose all that apply)
- Vagus Nerve Stimulation
- Laser Ablation
- Resection surgery
- None of the above

Based on your answers, your patient might benefit from the RNS System.

Get your profile and a list of questions to ask your doctor.
Unfortunately it appears your patient is not an appropriate candidate for the RNS^® System at this time.
The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.
If you are interested in learning more about the RNS® System, you can have an RNS^® System professional contact you by filling out the form below:
Name*
First Name Last Name
Email*
Specialty
Name of Center/Practice
Phone
City
State
Please input your question or topic of interest so we can better address your request*
By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

* Required fileds

NeuroPace, Inc. Announces Results of 7 Years of Clinical Trial Follow-up Demonstrating 72 Percent Seizure Reduction with the RNS® System – December 4, 2016